Helsinn Healthcare S.A.

Rated 4.00(2) — Helsinn Healthcare S.A.

Chemotherapy-induced nausea and vomiting (CINV) continues to be a major concern in cancer treatment. In fact, despite advances in oncological therapies and supportive care, more than 50% of patients undergoing emetogenic chemotherapy still experienceacute

Rated 4.38(8) — Helsinn Healthcare S.A.

Patients fighting cancer have to deal with Nausea and Vomiting, potential side effects related to chemotherapy. MASCC Antiemesis Tool (MAT) is the first Android application for Cancer patients receiving chemotherapy that helps their doctors in evaluating.

Rated 5.00(8) — Helsinn Healthcare S.A.

This guide is designed as a practical tool for the Oncologists, aimed at facilitating the decision making on the antiemetic therapy to be administered to patients undergoing a specific chemotherapy (CT) regimen. While it offers information on CT regimens’